Diese Übersetzung wird noch vorbereitet. Bis dahin zeigen wir vorübergehend die englische Originalversion.
Geschäft · 20.1.20101 Min. Lesezeit
Prospective Grant of Exclusive License: Monoclonal Antibodies Against Smallpox/Orthopoxviruses
Lokale automatische Übersetzung · Originalsprache der Quelle
Zusammenfassung
This is notice, in accordance with 35 U.S.C. 209(c)(1) and 37 CFR 404.7(a)(1)(i), that the National Institutes of Health (NIH), Department of Health and Human Services (HHS), is contemplating the grant of a an exclusive license to practice the following invention as embodied in the following patent applications: E-145-2004/0,1,2,3,4, Purcell et al., "Monoclonal Antibodies Against Orthopoxviruses", United States Patent Application 12/142,594, filed June 19, 2008 to BioFactura, Inc., having a place of business in Rockville, Maryland. The patent rights in this invention have been assigned to the United States of America.
Originalsprache der Quelle: Federal Register — Health and Human ServicesOriginalquelle öffnen →